Is Taysha Gene Therapies Inc (NASDAQ: TSHA) a Risk-Worthy Bet for Bold Investors?
In the last trading session, 1.32 million Taysha Gene Therapies Inc (NASDAQ:TSHA) shares changed hands as the company’s beta touched 0.96. With the company’s per
In the last trading session, 1.32 million Taysha Gene Therapies Inc (NASDAQ:TSHA) shares changed hands as the company’s beta touched 0.96. With the company’s per
During the recent session, Taysha Gene Therapies Inc (NASDAQ:TSHA)’s traded shares were 1.7 million, with the beta value of the company hitting 1.02. At the
In the latest trading session,, 1.12 million Taysha Gene Therapies Inc (NASDAQ:TSHA) shares changed hands as the company’s beta touched 1.01. With the company’s most
Taysha Gene Therapies Inc (NASDAQ:TSHA) has a beta value of 1.02 and has seen 5.92 million shares traded in the last trading session. The company,
During the last session, Taysha Gene Therapies Inc (NASDAQ:TSHA)’s traded shares were 22.17 million, with the beta value of the company hitting 0.95. At the
In the last trading session, 4.06 million shares of the Taysha Gene Therapies Inc (NASDAQ:TSHA) were traded, and its beta was 1.01. Most recently the
Taysha Gene Therapies Inc (NASDAQ:TSHA)’s traded shares stood at 3.58 million during the last session, with the company’s beta value hitting 1.02. At the close
Traders and investors usually benefit from premarket movers since it gives them a glimpse of what the market may do in the future. Electronic communication
© 2024, Powered by Smart TechOne